Schedule 13D ownership disclosure

Stealth BioTherapeutics Corp

Security class unavailable · CUSIP: 85788D100

Event date: 2019-05-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
266,701,555
Percent of class
63.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-031740
Form type
SC 13D/A
Filer
Morningside Venture (I) Investments Ltd
CIK
CIK 1770194
Filed
May 24, 2019
Reporting period
May 01, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub